Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_assertion description "[Blockade of VEGFR2 signaling using DC101 anti-VEGFR2 monoclonal antibody enhanced doxorubicin chemoresponse; this combined biochemotherapy inhibited tumor growth and decreased pulmonary metastases without overt toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_assertion evidence source_evidence_literature NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_assertion SIO_000772 16951193 NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_assertion wasDerivedFrom befree-20140225 NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_assertion wasGeneratedBy ECO_0000203 NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP623575.RA5E6X6P-Q3halhw8EMhi1CyCCXHOfbWedQCL6aqZfeUk130_provenance.